Aelis Farma SA

DB:69O Stock Report

Market Cap: €39.2m

Aelis Farma Future Growth

Future criteria checks 5/6

Aelis Farma is forecast to grow earnings and revenue by 33.8% and 24.6% per annum respectively while EPS is expected to decline by 14.2% per annum.

Key information

33.8%

Earnings growth rate

-14.2%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate24.6%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:69O - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263-8N/A01
12/31/2025113101N/A1061
12/31/20247-3N/A-41
6/30/202411-7-13-13N/A
3/31/202412-6-13-13N/A
12/31/202312-5-13-13N/A
9/30/202311-5-13-13N/A
6/30/202310-6-13-13N/A
3/31/20239-10-13-13N/A
12/31/20228-14-13-13N/A
9/30/20228-14-14-13N/A
6/30/20227-14-14-14N/A
3/31/20229-623N/A
12/31/20211111919N/A
9/30/20211022121N/A
6/30/2021932424N/A
3/31/2021511111N/A
12/31/20201-2-3-2N/A
12/31/20190-3N/AN/AN/A
12/31/20180-3N/AN/AN/A
12/31/20170-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 69O is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: 69O is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 69O is expected to become profitable in the next 3 years.

Revenue vs Market: 69O's revenue (24.6% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: 69O's revenue (24.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 69O's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y